Cargando…
A Public Dialogue to Inform the Use of Wider Genomic Testing When Used as Part of Newborn Screening to Identify Cystic Fibrosis
Cystic fibrosis (CF) has been included within the UK national newborn screening programme since 2007. The approach uses measures of immunoreactive trypsin (IRT) in dried blood spot samples obtained at day 5 of life. Samples which reveal IRT results >99.5th centile go on to be tested for a limited...
Autores principales: | Kinsella, Suzannah, Hopkins, Henrietta, Cooper, Lauren, Bonham, James R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149844/ https://www.ncbi.nlm.nih.gov/pubmed/35645286 http://dx.doi.org/10.3390/ijns8020032 |
Ejemplares similares
-
Confidentiality, public interest, and the human right to science: when can confidential information be used for the benefit of the wider community?
por: Dove, Edward S
Publicado: (2023) -
Newborn Screening for Cystic Fibrosis in Delaware
por: Shenoy, Ambika, et al.
Publicado: (2018) -
Wider Use of the School Plant
Publicado: (1911) -
When is cystic fibrosis not cystic fibrosis? The importance of appropriately classifying patients
por: Faro, Albert, et al.
Publicado: (2022) -
Cystic fibrosis diagnosed by state newborn screening: Or is
it?
por: Fox, Maura, et al.
Publicado: (2020)